Precision radiation aims to stall prostate cancer spread
NCT ID NCT04983095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding precise, high-dose radiation (SBRT) to standard hormone therapy can delay cancer progression in men with prostate cancer that has spread to 1-3 spots. About 118 participants will be randomly assigned to get SBRT plus standard care or standard care alone. The goal is to see if the radiation helps keep the cancer from growing longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
stereotactic body radiotherapy (SBRT) plus standard hormone therapy
What this could lead to
If it works, this could improve control of prostate cancer that has spread to a few spots, delaying the need for stronger treatments.
What could go wrong
This is a phase III trial but still early in recruitment. The benefit may be small, and radiation can cause side effects like fatigue or local irritation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Capio St Göran Hospital
RECRUITINGStockholm, Region Stockholm, Sweden
Contact Email: •••••@•••••
-
Karolinska University Hospital
RECRUITINGStockholm, Stockholm County, Sweden
Contact Email: •••••@•••••
-
Region Skåne
RECRUITINGLund, Lund, Sweden
Contact Email: •••••@•••••
-
Region Örebro Län
RECRUITINGÖrebro, Örebro County, Sweden
Contact Email: •••••@•••••
-
Ryhovs county hospital
RECRUITINGJönköping, Sweden
Contact Email: •••••@•••••
-
Södersjukhuset
RECRUITINGStockholm, Region Stockholm, Sweden
Contact Email: •••••@•••••
-
Umeå University hospital
RECRUITINGUmeå, Umea, 90331, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••